Rothschild & Co Asset Management US’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-224,946
| Closed | -$4.52M | – | 274 |
|
|
2020
Q4 | $4.52M | Sell |
224,946
-18,963
| -8% | -$381K | 0.06% | 232 |
|
|
2020
Q3 | $4.57M | Sell |
243,909
-41,436
| -15% | -$777K | 0.08% | 240 |
|
|
2020
Q2 | $6.41M | Buy |
285,345
+1,017
| +0.4% | +$22.8K | 0.09% | 250 |
|
|
2020
Q1 | $4.22M | Sell |
284,328
-49,461
| -15% | -$734K | 0.07% | 259 |
|
|
2019
Q4 | $6.44M | Sell |
333,789
-13,518
| -4% | -$261K | 0.07% | 275 |
|
|
2019
Q3 | $6.89M | Sell |
347,307
-216
| -0.1% | -$4.28K | 0.07% | 271 |
|
|
2019
Q2 | $7.34M | Buy |
347,523
+33,957
| +11% | +$717K | 0.08% | 273 |
|
|
2019
Q1 | $6.41M | Sell |
313,566
-22,364
| -7% | -$457K | 0.07% | 280 |
|
|
2018
Q4 | $6.69M | Buy |
335,930
+13,757
| +4% | +$274K | 0.08% | 281 |
|
|
2018
Q3 | $6.2M | Sell |
322,173
-6,668
| -2% | -$128K | 0.06% | 294 |
|
|
2018
Q2 | $5.02M | Buy |
328,841
+13,157
| +4% | +$201K | 0.05% | 301 |
|
|
2018
Q1 | $5.92M | Sell |
315,684
-10,653
| -3% | -$200K | 0.07% | 282 |
|
|
2017
Q4 | $6.28M | Sell |
326,337
-27,716
| -8% | -$533K | 0.07% | 274 |
|
|
2017
Q3 | $6.33M | Sell |
354,053
-6,527
| -2% | -$117K | 0.07% | 269 |
|
|
2017
Q2 | $6.44M | Sell |
360,580
-263,974
| -42% | -$4.71M | 0.07% | 273 |
|
|
2017
Q1 | $9.06M | Buy |
+624,554
| New | +$9.06M | 0.1% | 252 |
|